NWAM LLC’s Allergan plc AGN.PRA Stock Holding History

NWAM LLC’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-255	Closed	-$221K	–	344
2017 Q2	$221K	Sell	255 -50	-16%	-$41.9K	0.04%	270
2017 Q1	$259K	Sell	305 -17	-5%	-$14.1K	0.08%	239
2016 Q4	$246K	Buy	+322	New	+$243K	0.08%	234

Other funds holding AGN.PRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NWAM LLC's AGN.PRA Position: Q3 2017 in Review

NWAM LLC sold out of Allergan plc (AGN.PRA) in Q3 2017, closing a stake of 255 shares — an estimated $221K sold.

NWAM LLC first reported a position in AGN.PRA in Q4 2016 and held it in 3 quarters. The position peaked at $259K in Q1 2017. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2017.

NWAM LLC reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
NWAM LLC sold 255 Allergan plc shares in Q3 2017, an estimated $221K.
NWAM LLC first reported a position in Allergan plc in Q4 2016 and held it in 3 quarters.
NWAM LLC's Allergan plc position peaked at $259K in Q1 2017.
106 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on NWAM LLC's 13F filing for Q3 2017, filed 1 Nov 2017.